美国不同种族、年龄和性别白癜风诊断的发病率与患病率
结果显示,年龄和性别调整后的总体发病率为22.6/10万人年(95%CI 21.5-23.8),患病率为0.16%(95%CI 0.15%-0.17%);发病率和患病率在老年、西班牙裔/拉丁裔及亚裔美国人患者中较高。
要点
- 年龄和性别调整后总体发病率为22.6/10万人年,患病率为0.16%。
- 发病率最高年龄组为60-69岁,患病率最高年龄组为70岁及以上。
- 年龄调整后发病率最高为亚裔美国人,患病率最高为西班牙裔/拉丁裔。
核心结论
- 该横断面研究发现,白癜风诊断在老年患者、西班牙裔/拉丁裔患者和亚裔美国人患者中更为常见。
研究设计与样本
- 队列研究和横断面研究分析,纳入美国4个普查区域寻求医疗服务的儿童、青少年和成人的电子健康记录,发病率分析数据来自2015年1月1日至2019年12月31日,患病率分析数据来自2019年1月1日至12月31日。
主要发现
- 发病率分析纳入2 980 778例白癜风患者,平均(SD)年龄41.5(24.0)岁,57.0%为女性;患病率分析纳入1 057 534例,平均(SD)年龄43.4(24.7)岁,57.5%为女性。
- 年龄和性别调整后总体发病率为22.6/10万人年(95%CI 21.5-23.8),患病率为0.16%(95%CI 0.15%-0.17%)。
- 性别调整后发病率最高为60-69岁患者(25.3/10万人年;95%CI 22.2-28.6),患病率最高为70岁及以上患者(0.21%;95%CI 0.19%-0.23%)。
- 年龄调整后发病率最高为亚裔美国人(41.2/10万人年;95%CI 28.2-58.2),其次为西班牙裔/拉丁裔(37.3/10万人年;95%CI 25.7-52.4)、其他或多个种族(31.1/10万人年;95%CI 25.9-37.1)、黑人(29.6/10万人年;95%CI 26.0-33.6)和白人(18.7/10万人年;95%CI 17.5-20.0)。
- 年龄调整后患病率最高为西班牙裔/拉丁裔(0.29%;95%CI 0.20%-0.39%),其次为亚裔美国人(0.27%;95%CI 0.19%-0.35%)、其他或多个种族(0.24%;95%CI 0.20%-0.28%)、黑人(0.22%;95%CI 0.19%-0.24%)和白人(0.13%;95%CI 0.12%-0.14%)。
局限性
- 原文未述局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
IMPORTANCE: Vitiligo has substantial psychosocial consequences. Yet its burden is poorly established. OBJECTIVE: To estimate incidence and prevalence of diagnosed vitiligo across age, sex, and racial and ethnic subgroups in the US. DESIGN, SETTING, AND PARTICIPANTS: This analysis comprising a cohort study and cross-sectional study included electronic health records for health care-seeking children, adolescents, and adults across 4 US census regions. Data for the incidence analysis were obtained from January 1, 2015, through December 31, 2019, and data for the prevalence analysis were obtained from January 1 through December 31, 2019. Data were analyzed from December 13, 2022, to June 8, 2023. MAIN OUTCOMES AND MEASURES: The main outcomes were incidence (per 100 000 person-years [PY]) and prevalence of diagnosed vitiligo overall and by age, race and ethnicity, and sex. RESULTS: A total of 2 980 778 patients with vitiligo were included in the incidence analysis (mean [SD] age, 41.5 [24.0] years; 57.0% female; 1.4% Asian American; 12.9% Black; 1.5% Hispanic/Latino; 77.3% White; 6.9% other or multiracial) and 1 057 534 in the prevalence analysis (mean [SD] age, 43.4 [24.7] years; 57.5% female; 1.7% Asian American, 14.7% Black, 1.4% Hispanic/Latino; 75.7% White; 6.6% other or multiracial). Age- and sex-adjusted overall incidence rate (IR) of diagnosed vitiligo was 22.6 per 100 000 PY (95% CI, 21.5-23.8 per 100 000 PY), and prevalence was 0.16% (95% CI, 0.15%-0.17%). Sex-adjusted IR was highest among patients aged 60 to 69 years (25.3 per 100 000 PY; 95% CI, 22.2-28.6 per 100 000 PY), and prevalence was highest among patients aged 70 years or older (0.21%; 95% CI, 0.19%-0.23%). The highest age-adjusted IR was observed among Asian American patients (41.2 per 100 000 PY; 95% CI, 28.2-58.2 per 100 000 PY), followed by Hispanic/Latino patients (37.3 per 100 000 PY; 95% CI, 25.7-52.4 per 100 000 PY), patients reporting other or multiple races (31.1 per 100 000 PY; 95% CI, 25.9-37.1 per 100 000 PY), Black patients (29.6 per 100 000 PY; 95% CI, 26.0-33.6 per 100 000 PY), and White patients (18.7 per 100 000 PY; 95% CI, 17.5-20.0 per 100 000 PY). The highest age-adjusted prevalence was observed among Hispanic/Latino patients (0.29%; 95% CI, 0.20%-0.39%), followed by Asian American patients (0.27%; 95% CI, 0.19%-0.35%), patients reporting other or multiple races (0.24%; 95% CI, 0.20%-0.28%), Black patients (0.22%; 95% CI, 0.19%-0.24%), and White patients (0.13%; 95% CI, 0.12%-0.14%). CONCLUSIONS AND RELEVANCE: This cross-sectional study found that vitiligo diagnosis was more common in older patients, Hispanic/Latino patients, and Asian American patients.
引用
- Mastacouris N, Strunk A, Garg A, et al. Incidence and Prevalence of Diagnosed Vitiligo According to Race and Ethnicity, Age, and Sex in the US. JAMA Dermatol. 2023. PMID: 37466934. doi:10.1001/jamadermatol.2023.2162
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。